Why Innovation in Inflammatory Bowel Disease Drug Development Will Impact Your Practice
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference8 articles.
1. Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis;Fasanmade;Int J Clin Pharmacol Ther,2010
2. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease;Afif;Am J Gastroenterol,2010
3. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease;Rimola;Gut,2009
4. Development of the Crohn's disease digestive damage score, the Lemann score;Pariente;Inflamm Bowel Dis,2010
5. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health;Peyrin-Biroulet;Inflamm Bowel Dis,2010
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gastrointestinal Tract;The Immunoassay Handbook;2013
2. Some data on inflammatory bowel diseases in Hungary: analytical data on ulcerative colistis;Orvosi Hetilap;2012-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3